Test Price
2,800 AED✅ Home Collection Available
PRKD1 Gene Congenital Heart Defects and Ectodermal Dysplasia Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next-Generation Sequencing (NGS) test analyzes the entire coding region of the PRKD1 gene to detect variants associated with congenital heart defects and ectodermal dysplasia. It provides comprehensive analysis to aid pediatric cardiologists and medical geneticists in accurate diagnosis and treatment planning.
| Feature | Our Test (DNA Labs UAE) | Standard Local Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – Full gene coverage, variant calling with Illumina NovaSeq X Plus | Sanger sequencing (targeted exons only) or limited panel |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Sensitivity / Depth | 99.9% clinical sensitivity, >100x coverage | ~95% sensitivity, lower resolution |
| Price | 2,800 AED (all-inclusive) | 2,300–3,500 AED (often without genetic counseling) |
| Post-Test Support | Telephonic clinical guidance + comprehensive report | Report only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics | DHA Registration ID: 9294403) notes: "As a medical geneticist, I have seen families gain crucial clarity from early genetic diagnosis of PRKD1-related conditions. This NGS test provides essential insights, but it is imperative that results are interpreted alongside a complete clinical evaluation and thorough pedigree analysis."
Important Medication and Treatment Advisory
Do not discontinue or alter any prescribed medication or treatment plan without consulting the ordering physician. Always inform your doctor about any genetic test results before making changes.
Safety Exclusion Criteria & Emergency Red Flags
- This test is not a standalone diagnostic tool; it requires pre-test genetic counseling and pedigree analysis.
- Do not proceed with sample collection if the patient has unstable cardiac status without medical clearance.
- Seek immediate medical attention if your child experiences: cyanosis (blue lips/skin), severe shortness of breath, chest pain, or loss of consciousness.
Patient FAQ & Clinical Guidance
1. What does the PRKD1 gene test look for?
This NGS test sequences the entire coding region of PRKD1 to identify DNA variants causing congenital heart defects and ectodermal dysplasia. It can confirm a clinical diagnosis, guide family planning, and inform personalized management by a multidisciplinary team including neonatologists, pediatricians, and cardiologists.
2. How is the sample collected and is it painful?
Sample collection uses a simple blood draw, extracted DNA, or a single drop of blood on an FTA card—minimally invasive and virtually painless. Our DHA-licensed mobile phlebotomist visits your home, ensures cold-chain transport, and the process takes less than 15 minutes.
3. Who should consider this test?
Individuals with a personal or family history of congenital heart defects, ectodermal dysplasia, or suspicious neonatal features should consider this test. It is especially valuable for parents planning future pregnancies, newborns with ambiguous cardiac findings, and adults seeking a definitive molecular diagnosis.
4. What are the pre-requisites for sample collection?
A clinical history of the patient and a genetic counselling session to draw a pedigree chart of family members affected with PRKD1-related conditions must be completed before sample collection. Our genetic counselor will guide you through this step.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored securely, and used solely for diagnostic purposes with explicit consent. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | PRKD1 Gene Congenital Heart Defects and Ectodermal Dysplasia Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral), DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene coding region analysis |
| ICD-10-CM Code | Q24.9, Q82.4 |
| LOINC Code | 80336-9 |
| DHA Facility License & Address | DHA License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians